FindMyKOL

Benjamin Besse, MD

Enriched profile

Director of Clinical Research, Gustave Roussy · Gustave Roussy

ORCID↗RPPS

Licensed physician in France · practises at Institut Gustave Roussy Site Ville Juif · RPPS register, 2026-10-19

✓ Itemized profile
Region🇫🇷 FranceSpecialtyOncologie option médicaleFocusLung Cancer Treatments and Mutations+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceNone verifiedPaymentsNot attributedNIH fundingNone on fileWhy? →

Benjamin Besse is Director of Clinical Research, Gustave Roussy at Gustave Roussy. OpenAlex indexes 1,599 publications with 58,741 citations (h-index 102); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.

Data verified 8 Nov 2026

Overview

Updated 8 Nov 2026

Benjamin Besse is Director of Clinical Research, Gustave Roussy. The public record shows 1,599 publications with 58,741 citations (h-index 102), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 13 registered clinical trials.

  • Most recent indexed publication: 2026 · Cancer discovery
  • Top research focus: Lung Cancer Treatments and Mutations
  • 13 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 8 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)7 trialsSmall Cell Lung Carcinoma5 trialsCarcinoma, Small Cell2 trialsThymoma2 trialsMelanoma1 trialMesothelioma, Malignant1 trialMesothelioma1 trialThymic epithelial tumor1 trialBladder / Urothelial CancerLeukemia (AML/ALL/CML/CLL)Prostate CancerViral Hepatitis (B/C)IBS / Functional GIMyasthenia GravisNeuro-Oncology / GliomaChronic Kidney DiseaseSarcomaKidney Cancer / RCCRheumatoid ArthritisAcromegalyHepatobiliary CancerIdiopathic Pulmonary FibrosisLupus (SLE)Gastroesophageal CancerPancreatic CancerCOVID-19Ovarian / Gynecologic CancerLymphomaMDS / MPNAtrial FibrillationMultiple MyelomaHead & Neck CancerTuberculosisColorectal CancerCOPDBreast Cancer

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Research StudiesCancer Genomics and Diagnostics

Works with

trial sponsors and companies reporting payments
Intergroupe Francophone de Cancerologie ThoraciqueClinical trials3Industry payments—European Organisation for Research and Treatment of Cancer - EORTCClinical trials2Industry payments—Gustave Roussy, Cancer Campus, Grand ParisClinical trials2Industry payments—Assistance Publique - Hôpitaux de ParisClinical trials1Industry payments—CelgeneClinical trials1Industry payments—MedSIRClinical trials1Industry payments—Morten Mau-SoerensenClinical trials1Industry payments—Tiziana Life Sciences LTDClinical trials1Industry payments—UnicancerClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,599publications

Publications indexed by OpenAlex, matched via ORCID. 56 in PubMed. Counts exclude supporting files.

58,741citations

Citations across these publications.

102h-index

H-index from these publications. i10-index 540.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

Updated 8 Nov 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

All 13 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 8 Nov 2026

474 congress contributions (2005–2026) across AACR, ASCO, ASH, ASTRO, ESMO, ESTRO Congress, IASLC, ISPOR Europe per OpenAlex. The most recent:

All 474 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 8 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 56 publications: search, sort and filter.Explore →

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    PhD

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗

Editorial & leadership roles

journal and society appointments
  • President

    European Organisation for Research and Treatment of Cancer (EORTC)

    2026
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eortc.org ↗
  • President-Elect

    European Organisation for Research and Treatment of Cancer (EORTC)

    2026
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.